Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily

OBJECTIVES: Antiretroviral therapy during pregnancy is recommended to reduce the risk of mother-to-child transmission of HIV and for maternal care management. Physiological changes during pregnancy can affect pharmacokinetics, potentially altering pharmacological activity. We therefore evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zorrilla, CD, Wright, R, Osiyemi, OO, Yasin, S, Baugh, B, Brown, K, Coate, B, Verboven, P, Mrus, J, Falcon, R, Kakuda, TN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231999/
https://www.ncbi.nlm.nih.gov/pubmed/23731450
http://dx.doi.org/10.1111/hiv.12047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231999/
https://www.ncbi.nlm.nih.gov/pubmed/23731450
http://dx.doi.org/10.1111/hiv.12047

Ejemplares similares